Navigation Links


BioLineRx at Biology News

BioLineRx at Biology Products
BioLineRx at Biology Technology
BioLineRx at Medicine News
BioLineRx at Medicine Products
BioLineRx at Medicine Technology

BioLineRx Presents Data From Successful Phase I Trial for BL-1020 in Schizophrenia at American Psychiatric Association Conference

SAN DIEGO--(BUSINESS WIRE)--May 22, 2007 - BioLineRx Ltd.(TASE:BLRX), Israel's leading drug development company, reportedtoday data from its Phase I trial of BL-1020, the first GABAenhanced antipsychotic clinical candidate for the treatment ofschizophrenia. The trial demonstrated that the compound was welltolerated and demonstrated biochemical evidence of dopamineblockade which is indicativ...

BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming Clinical Conferences

JERUSALEM--(BUSINESS WIRE)--May 17, 2007 - BioLineRx Ltd. (TASE:BLRX), Israel's leading drug development company, announced todaythat abstracts containing data from its successfully completedphase I clinical trails of BL-1020, first in class GABA-enhancedantipsychotic for the treatment of schizophrenia, have beenaccepted for poster presentations at three leading scientificconferences. The d...

BioLineRx Presents Data on BL-1040 at Cardiovascular Revascularization Therapies Conference Demonstrating Potential to Reduce Deterioration of Infarcted Heart Tissue and Maintain Functionality

JERUSALEM--(BUSINESS WIRE)--Mar 7, 2007 - BioLineRx Ltd.(TASE:BLRX), Israel's leading drug development company, reportedtoday pre-clinical data from trials of BL-1040 demonstrating thatBL-1040 is effective in preventing deterioration of the myocardiumafter a myocardial infarction (MI), thereby reducing left ventricledilatation and eventual heart failure in a pig model. ProfessorJonathan Leo...
Other TagsDysfunctionPrisonerOverdoseiGATEiGATE
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
(Date:8/28/2008)... , Quicker microwave meals that use less energy m...hes and, according to the material scientists resp...c waste remediation. , , "Currently, food heate...se the dishes are transparent to microwaves," says...y mineralogy, College of Agricultural Sciences at ...
(Date:8/28/2008)... , Researchers at The University of Nottingham ha...to develop a new drug that could ease the sufferin...ts who are unable to take beta-blockers. , In th... and most are able to have their symptoms effectiv...drugs which stop adrenaline from making the heart ...
(Date:8/28/2008)... , BIRMINGHAM, Ala. -- Intravenous magnesium su... the risk for handicapping cerebral palsy in half,...a at Birmingham (UAB) obstetrician Dwight Rouse, M...w England Journal of Medicine. , Cerebral palsy...ting control of movement and posture and limiting ...
(Date:8/27/2008)... ,, DALLAS Aug. 28, 2008 Researchers at UT...ce that the brain must create new nerve cells for ...ssion-like behavior. , In addition, the research...e same biochemical pathway to exert their effects.... mechanisms of antidepressants and provide a new d...
Breaking Biology News(10 mins):Ceramic material revs up microwaving 2New beta-blocker to offer hope to heart and lung sufferers 2Common treatment to delay labor decreases preterm infants' risk for cerebral palsy 2Common treatment to delay labor decreases preterm infants' risk for cerebral palsy 3Antidepressants need new nerve cells to be effective, UT Southwestern researchers find 2Why do astronauts suffer from space sickness 3F 20003 1Why do astronauts suffer from space sickness 3F 20003 2Lilly Announces Changes in Key Leadership Roles 20000 1Lilly Announces Changes in Key Leadership Roles 20000 2Lilly Announces Changes in Key Leadership Roles 20000 3Lilly Announces Changes in Key Leadership Roles 20000 4Lilly Announces Changes in Key Leadership Roles 20000 5VA Secretary Appoints Panel of National Suicide Experts 19997 1VA Secretary Appoints Panel of National Suicide Experts 19997 2 C O R R E C T I O N Rosetta Genomics Ltd 5557 1 C O R R E C T I O N Rosetta Genomics Ltd 5557 2 C O R R E C T I O N Rosetta Genomics Ltd 5557 3 C O R R E C T I O N Rosetta Genomics Ltd 5557 4 C O R R E C T I O N Rosetta Genomics Ltd 5557 5 C O R R E C T I O N Rosetta Genomics Ltd 5557 6 C O R R E C T I O N Rosetta Genomics Ltd 5557 7 C O R R E C T I O N Rosetta Genomics Ltd 5557 8 C O R R E C T I O N Rosetta Genomics Ltd 5557 9 C O R R E C T I O N Rosetta Genomics Ltd 5557 10 C O R R E C T I O N Rosetta Genomics Ltd 5557 11 C O R R E C T I O N Rosetta Genomics Ltd 5557 12 C O R R E C T I O N Rosetta Genomics Ltd 5557 13 C O R R E C T I O N Rosetta Genomics Ltd 5557 14 C O R R E C T I O N Rosetta Genomics Ltd 5557 15 C O R R E C T I O N Rosetta Genomics Ltd 5557 16 C O R R E C T I O N Rosetta Genomics Ltd 5557 17 C O R R E C T I O N Rosetta Genomics Ltd 5557 18 C O R R E C T I O N Rosetta Genomics Ltd 5557 19 C O R R E C T I O N Rosetta Genomics Ltd 5557 20
Other Contentsorbitalorbitalorbitalorbitalorchiectomyorchitisorgasmorgasmorthopaedicsorganicorganicorganicorganicorganicorganicorganicorganicosmolalityorificeorifice